Skip to main content

Advertisement

SpringerLink
Log in

IL-8 Is Involved in Estrogen-Related Receptor α-Regulated Proliferation and Migration of Colorectal Cancer Cells

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background and Aims

Studies revealed that estrogenic signals were involved in the development of colorectal cancer (CRC), while the roles of estrogen related receptor (ERR) on the progression of CRC have not been well illustrated. Its roles on the development of CRC were investigated.

Methods

The expression of ERRα/β/γ in CRC cells were measured. The effects of ERRα on cell proliferation, migration and expression of cytokines were investigated accordingly.

Results

Our data revealed that the expression of ERRα, while not ERRβ or ERRγ, was significantly increased in CRC cells and clinical CRC tissues. Both the inverse agonist of ERRα (XCT-790) and si-ERRα can inhibit the proliferation of CRC cells. XCT-790 treatment can also suppress the wound healing and in vitro migration of CRC cells. Cytokine assays showed that XCT-790 can significantly decrease the expression of interleukin-8 (IL-8), while not IL-4, IL-6, IL-8, IL-9, IL-10, IL-18, IFN-γ, or TGF-β, in CRC cells. Over expression of ERRα increased the expression of IL-8. Luciferase assay showed XCT-790 decreased the promoter activity of IL-8. XCT-790 can increase the decay of IL-8 mRNA in SW480 cells. The recombinant IL-8 (rIL-8) can rescue XCT-790 induced suppression of proliferation and migration of CRC cells. XCT-790 can decrease the phosphorylation of ERK1/2 and STAT3, two downstream signal molecules of IL-8, in CRC cells. While rIL-8 can markedly attenuate XCT-790 induced dephosphorylation of ERK1/2 and STAT3.

Conclusion

Our data showed that ERRα can trigger the proliferation and migration of CRC cells via up regulation of IL-8. Therefor targeted inhibition of ERRα/IL-8 might be a potential approach for CRC treatment and drug development.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5–29.

    Article  PubMed  Google Scholar 

  2. Zhang X, Wu K, Giovannucci EL, Ma J, Colditz GA, Fuchs CS, et al. Early life body fatness and risk of colorectal cancer in U.S. women and men—results from two large cohort studies. Cancer Epidemiol Prev Biomark [Internet]. 2015 [cited 2017 May 13]; Available from: http://cebp.aacrjournals.org/content/early/2015/03/13/1055-9965.EPI-14-0909-T.

  3. Williams C, DiLeo A, Niv Y, Gustafsson J-Å. Estrogen receptor beta as target for colorectal cancer prevention. Cancer Lett. 2016;372:48–56.

    Article  CAS  PubMed  Google Scholar 

  4. Simon MS, Chlebowski RT, Wactawski-Wende J, et al. Estrogen plus progestin and colorectal cancer incidence and mortality. J Clin Oncol Off J Am Soc Clin Oncol. 2012;30:3983–3990.

    Article  Google Scholar 

  5. Foster PA. Oestrogen and colorectal cancer: mechanisms and controversies. Int J Colorectal Dis. 2013;28:737–749.

    Article  PubMed  Google Scholar 

  6. Barzi A, Lenz AM, Labonte MJ, Lenz H-J. Molecular pathways: estrogen pathway in colorectal cancer. Clin Cancer Res. 2013;19:5842–5848.

    Article  CAS  PubMed  Google Scholar 

  7. Witte D, Chirala M, Younes A, Li Y, Younes M. Estrogen receptor beta is expressed in human colorectal adenocarcinoma. Hum Pathol. 2001;32:940–944.

    Article  CAS  PubMed  Google Scholar 

  8. Hartman J, Edvardsson K, Lindberg K, et al. Tumor repressive functions of estrogen receptor beta in SW480 colon cancer cells. Cancer Res. 2009;69:6100–6106.

    Article  CAS  PubMed  Google Scholar 

  9. Giguère V, Yang N, Segui P, Evans RM. Identification of a new class of steroid hormone receptors. Nature. 1988;331:91–94.

    Article  PubMed  Google Scholar 

  10. Gallet M, Vanacker J-M. ERR receptors as potential targets in osteoporosis. Trends Endocrinol Metab. 2010;21:637–641.

    Article  CAS  PubMed  Google Scholar 

  11. Suzuki T, Miki Y, Moriya T, et al. Estrogen-related receptor α in human breast carcinoma as a potent prognostic factor. Cancer Res. 2004;64:4670–4676.

    Article  CAS  PubMed  Google Scholar 

  12. Stein RA, Chang C, Kazmin DA, et al. Estrogen-related receptor α is critical for the growth of estrogen receptor-negative breast cancer. Cancer Res. 2008;68:8805–8812.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Stein RA, McDonnell DP. Estrogen-related receptor alpha as a therapeutic target in cancer. Endocr Relat Cancer. 2006;13:S25–S32.

    Article  CAS  PubMed  Google Scholar 

  14. Cavallini A, Notarnicola M, Giannini R, et al. Oestrogen receptor-related receptor alpha (ERRα) and oestrogen receptors (ERα and ERβ) exhibit different gene expression in human colorectal tumour progression. Eur J Cancer. 2005;41:1487–1494.

    Article  CAS  PubMed  Google Scholar 

  15. Bernatchez G, Giroux V, Lassalle T, Carpentier AC, Rivard N, Carrier JC. ERRα metabolic nuclear receptor controls growth of colon cancer cells. Carcinogenesis. 2013;34:2253–2261.

    Article  CAS  PubMed  Google Scholar 

  16. Chen Z-J, Wei W, Jiang G-M, et al. Activation of GPER suppresses epithelial mesenchymal transition of triple negative breast cancer cells via NF-κB signals. Mol Oncol. 2016;10:775–788.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Mager LF, Wasmer M-H, Rau TT, Krebs P. Cytokine-induced modulation of colorectal cancer. Front Oncol [Internet]. 2016 [cited 2017 May 18]; 6. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4835502/.

  18. Fujimura T, Takahashi S, Urano T, et al. Increased expression of estrogen-related receptor α (ERRα) is a negative prognostic predictor in human prostate cancer. Int J Cancer. 2007;120:2325–2330.

    Article  CAS  PubMed  Google Scholar 

  19. Deblois G, Hall JA, Perry M-C, et al. Genome-wide identification of direct target genes implicates estrogen-related receptor alpha as a determinant of breast cancer heterogeneity. Cancer Res. 2009;69:6149–6157.

    Article  CAS  PubMed  Google Scholar 

  20. Deblois G, Chahrour G, Perry M-C, Sylvain-Drolet G, Muller WJ, Giguère V. Transcriptional control of the ERBB2 amplicon by ERRalpha and PGC-1beta promotes mammary gland tumorigenesis. Cancer Res. 2010;70:10277–10287.

    Article  CAS  PubMed  Google Scholar 

  21. Tam IS, Giguère V. There and back again: the journey of the estrogen-related receptors in the cancer realm. J Steroid Biochem Mol Biol. 2016;157:13–19.

    Article  CAS  PubMed  Google Scholar 

  22. Fradet A, Sorel H, Bouazza L, et al. Dual function of ERRα in breast cancer and bone metastasis formation: implication of VEGF and osteoprotegerin. Cancer Res. 2011;71:5728–5738.

    Article  CAS  PubMed  Google Scholar 

  23. Boudjadi S, Bernatchez G, Beaulieu J-F, Carrier JC. Control of the human osteopontin promoter by ERRα in colorectal cancer. Am J Pathol. 2013;183:266–276.

    Article  CAS  PubMed  Google Scholar 

  24. Wu Y-M, Chen Z-J, Liu H, et al. Inhibition of ERRα suppresses epithelial mesenchymal transition of triple negative breast cancer cells by directly targeting fibronectin. Oncotarget. 2015;6:25588–25601.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Dwyer MA, Joseph JD, Wade HE, et al. WNT11 expression is induced by estrogen-related receptor α and β-catenin and acts in an autocrine manner to increase cancer cell migration. Cancer Res. 2010;70:9298–9308.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Ning Y, Manegold PC, Hong YK, et al. Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models. Int J Cancer. 2011;128:2038–2049.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Mizukami Y, Jo W-S, Duerr E-M, et al. Induction of interleukin-8 preserves the angiogenic response in HIF-1α-deficient colon cancer cells. Nat Med. 2005;11:992–997.

    CAS  PubMed  Google Scholar 

  28. Rubie C, Frick VO, Pfeil S, et al. Correlation of IL-8 with induction, progression and metastatic potential of colorectal cancer. World J Gastroenterol WJG. 2007;13:4996–5002.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Oncology, The Central Hospital of Yongzhou, No. 396, Yiyun Road, Lengshuitan District, Yongzhou City, 425000, China

    Sijuan Ding, Zhaohui Tang, Yongjun Jiang, Honglin Huang, Pengfei Luo, Bohua Qing, Siyuan Zhang & Ruoting Tang

Authors
  1. Sijuan Ding
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhaohui Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yongjun Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Honglin Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Pengfei Luo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Bohua Qing
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Siyuan Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ruoting Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zhaohui Tang.

Ethics declarations

Conflict of interest

The authors declare no conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ding, S., Tang, Z., Jiang, Y. et al. IL-8 Is Involved in Estrogen-Related Receptor α-Regulated Proliferation and Migration of Colorectal Cancer Cells. Dig Dis Sci 62, 3438–3446 (2017). https://doi.org/10.1007/s10620-017-4779-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-017-4779-4

Keywords

Search

Navigation